from NDTV News - Special https://ift.tt/3n5axcH
The Drugs Controller General of India (DCGI) on Wednesday granted conditional permission for phases 1 and 2 human clinical trial of the COVID-19 vaccine candidate developed by the Pune-based Gennova...
from NDTV News - Special https://ift.tt/3n5axcH
from NDTV News - Special https://ift.tt/3n5axcH
No comments:
Post a Comment